Biobank-based research on digestive peritoneal carcinomatosis (the BIG-RENAPE Biobank)

Authors

  • Laurent Villeneuve Unit of Clinical Research, Department of General and Digestive Surgery, Hospital of Lyon Sud, Lyon http://orcid.org/0000-0002-8713-7821
  • Peggy Jourdan-Enfer Unit of Clinical Research, Department of General and Digestive Surgery, Hospital of Lyon Sud, Lyon
  • Frédéric Bibeau Department of Pathology, Val d’Aurelle Montpellier Cancer Centre, Montpellier
  • Nicole Fabien Department of Immunology, Unit of Autoimmunity, Hospital of Lyon Sud, Lyon; Biologic Research Centre, Hospital of Lyon Sud, Lyon
  • Elisabeth Blasco Department of Immunology, Unit of Autoimmunity, Hospital of Lyon Sud, Lyon; Biologic Research Centre, Hospital of Lyon Sud, Lyon
  • Alexandra Traverse-Glehen Biologic Research Centre, Hospital of Lyon Sud, Lyon; 5Department of Pathology, Hospital of Lyon Sud, Lyon
  • Olivier Glehen Unit of Clinical Research, Department of General and Digestive Surgery, Hospital of Lyon Sud, Lyon

DOI:

https://doi.org/10.4081/joper.2016.12

Keywords:

Biobanking, tissue banking., biospecimen research, prospective clinical database, tissue banking

Abstract

Access to good quality biological samples is a prerequisite for highlevel translational research. The BIG-RENAPE Biobank has been established by the French hyperthermic intraperitoneal chemotherapy centers involved in the management of peritoneal surface malignancies. The Biobank is a core facility aiming to support researchers who conduct studies with sample collections, both within and outside the Big- RENAPE Network. The Biobank is certified according to NFS 96-900 and has been launched in February 2016 as a service of processing, storage and transfer of high quality biological (plasma, serum, buffy coat) and tissue (formalin-fixed-paraffin-embedded) samples from patients with digestive peritoneal carcinomatosis. Biospecimens are collected at each stage of diagnostic and therapeutic care. The patient and his derivates are anonymized and registered in a web database reporting disease status, treatments, surgical procedures, pathological diagnosis, quality of life’s assessment and long term follow-up. All participants have given their informed consent before any sample. The Biobank was approved by the local Ethical Committee, based on the assessed compliance to French regulatory rules. The Biobank is located in the Centre Hospitalier Lyon (SudBioTech), which is known to be an expert center in the management of the peritoneal carcinomatosis. Research projects that require material stored in the Biobank are submitted by specific form and evaluated by the BIG-RENAPE Scientific Committee. A material transfer agreement is agreed with the recipient before samples are allowed to be sent from the Biobank.

Downloads

Download data is not yet available.

Downloads

Published

2016-06-14

How to Cite

1.
Villeneuve L, Jourdan-Enfer P, Bibeau F, Fabien N, Blasco E, Traverse-Glehen A, Glehen O. Biobank-based research on digestive peritoneal carcinomatosis (the BIG-RENAPE Biobank). J Peritoneum [Internet]. 2016 Jun. 14 [cited 2024 Nov. 21];1(1). Available from: https://joper.pagepress.net/index.php/joper/article/view/12

Issue

Vol 1, No 1 (2016)

Section

Special Articles

License

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

An Open Access Publication is one that meets the following two conditions:

  1. the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  2. a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.